Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Osteoarthritic Knee Pain
NCT04224584Phase 2Completed
- Start
- Jan 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of duloxetine in osteoarthritis (OA) (2 arms). Primary endpoints: Pressure Pain Thresholds at 10 weeks, Temporal Summation of Pain at 10 weeks and 2 more. Started Jan 2020; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04224584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224584.